Back to top

Image: Bigstock

Top Ranked Income Stocks to Buy for September 27th

Read MoreHide Full Article

Here are four stocks with buy rank and strong income characteristics for investors to consider today, September 27th:

Brixmor Property Group Inc. (BRX - Free Report) : This real estate investment trust company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.

This Zacks Rank #2 (Buy) company has a dividend yield of 5.6%, compared with the industry average of 5.2%. Its five-year average dividend yield is 4.9%.

Cementos Pacasmayo S.A.A. (CPAC - Free Report) : This cement company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.1% over the last 60 days.

This Zacks Rank #2 company has a dividend yield of 5.9%, compared with the industry average of 0%. Its five-year average dividend yield is 4.2%.

Cedar Fair, L.P. (FUN - Free Report) : This amusement parks operator has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.4% over the last 60 days.

This Zacks Rank #2 company has a dividend yield of 6.4%, compared with the industry average of 0%. Its five-year average dividend yield is 5.8%.

Cedar Fair, L.P. Dividend Yield (TTM)

Cedar Fair, L.P. Dividend Yield (TTM)

Cedar Fair, L.P. dividend-yield-ttm | Cedar Fair, L.P. Quote

Green Plains Partners LP (GPP - Free Report) : This provider of fuel storage and transportation services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.1% over the last 60 days.

This Zacks Rank #2 company has a dividend yield of 14.4%, compared with the industry average of 0%. Its five-year average dividend yield is 9.5%.

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Published in